Quinto de'Stampi, Italy

Vincenzo Olgiati

This inventor holds 1 USPTO granted patent. Top assignee: Polichem S.a.. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vincenzo Olgiati. Retrieved from https://idiyas.com/inventor/vincenzo-olgiati

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 57(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Vincenzo Olgiati

Introduction

Vincenzo Olgiati is a notable inventor based in Quinto de'Stampi, Italy. He has made significant contributions to the field of chemistry, particularly in the development of pharmaceutical compounds. His work has led to the creation of innovative derivatives that have potential applications in various therapeutic areas.

Latest Patents

Vincenzo Olgiati holds a patent for "Diastereomerically pure 3-oxo and 3-thioxo-4-aza-androstan derivatives." This patent showcases his expertise in synthesizing complex chemical structures that can be utilized in drug development. His innovative approach to creating these compounds highlights his commitment to advancing pharmaceutical science.

Career Highlights

Throughout his career, Vincenzo has been associated with Polichem S.a., a company known for its focus on pharmaceutical research and development. His role at Polichem has allowed him to collaborate with other talented professionals in the industry, further enhancing his contributions to the field.

Collaborations

Vincenzo has worked alongside esteemed colleagues such as Stefano Poli and Roberto Girardello. Their collaborative efforts have fostered an environment of innovation and creativity, leading to the successful development of new chemical entities.

Conclusion

Vincenzo Olgiati's work exemplifies the spirit of innovation in the pharmaceutical industry. His patent and collaborations reflect his dedication to advancing scientific knowledge and improving healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…